Journal article · 1998
Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients
Annals of Hematology, 76(2), 73–80 · Published 12 March 1998 · DOI 10.1007/s002770050366
In brief
“Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients” is a 1998 journal article by Gerhard Behre and 6 co-authors, published in Annals of Hematology. OpenAlex counts 54 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 54
- Most cited in
- 2012 (2)
- Field-weighted impact
- 1.48
- References
- 37
- Authors
- 7
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Behre, G., Link, H., Maschmeyer, G., Meyer, P., Paaz, U., Wilhelm, M., & Hiddemann, W. (1998). Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients. Annals of Hematology, 76(2), 73–80. https://doi.org/10.1007/s002770050366
MLA 9
Behre, Gerhard, et al. “Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.” Annals of Hematology, vol. 76, no. 2, 1998, pp. 73–80. https://doi.org/10.1007/s002770050366.
Chicago
Behre, Gerhard, Hartmut Link, Georg Maschmeyer, Peter Meyer, U. Paaz, Martin Wilhelm, and Wolfgang Hiddemann. 1998. “Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.” Annals of Hematology 76 (2): 73–80. https://doi.org/10.1007/s002770050366.
Harvard
Behre, G. et al. (1998) ‘Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients’, Annals of Hematology, 76(2), pp. 73–80. doi:10.1007/s002770050366.
IEEE
G. Behre et al., “Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients,” Annals of Hematology, vol. 76, no. 2, pp. 73–80, 1998, doi: 10.1007/s002770050366.
BibTeX
@article{behre1998meropenem,
title = {{Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients}},
author = {Behre, Gerhard and Link, Hartmut and Maschmeyer, Georg and Meyer, Peter and Paaz, U. and Wilhelm, Martin and Hiddemann, Wolfgang},
journal = {Annals of Hematology},
year = {1998},
volume = {76},
number = {2},
pages = {73--80},
doi = {10.1007/s002770050366},
url = {https://doi.org/10.1007/s002770050366}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2012 | 2 | |
| 2013 | 2 | |
| 2014 | 2 | |
| 2015 | 2 | |
| 2020 | 1 | |
| 2021 | 2 | |
| 2023 | 1 | |
| 2024 | 1 |
Its field-weighted citation impact is 1.48: it has been cited 1.48 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- meropenem
- ceftazidime
- amikacin
- febrile neutropenia
- empirical antibiotic therapy
- combination antibiotic therapy
- hematologic malignancies
- solid tumors
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Behre, G., Link, H., Maschmeyer, G., Meyer, P., Paaz, U., Wilhelm, M., & Hiddemann, W. (1998). Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients. Annals of Hematology, 76(2), 73–80. https://doi.org/10.1007/s002770050366
How many times has this paper been cited?
54 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Gerhard Behre, Hartmut Link, Georg Maschmeyer, Peter Meyer, U. Paaz, Martin Wilhelm, Wolfgang Hiddemann.
What is the DOI of this paper?
10.1007/s002770050366, permanently at https://doi.org/10.1007/s002770050366. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.